PharmaEssentia dividend and valuation
Valuation
PharmaEssentia paid $1.49 per share in dividends over the last 12 months (yield 0.1%). Last ex-dividend date: July 9, 2026. The P/E ratio is 74.1. The average price target of 8 analysts is $1,437.27.
What would PharmaEssentia's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 22, 2026
PharmaEssentia compared with similar companies
PharmaEssentia's P/E (trailing 12 months): 74.1, +158% against the median of a group of 11 similar companies (28.7).
| Metric | PharmaEssentia | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 74.1 | 28.7 | 17.9 – 56.8 | High |
| Forward P/E | 29.3 | 24.3 | 17.9 – 29.1 | High |
| EV/EBITDA | 41.5 | 18.3 | 13.8 – 28.7 | High |
| Price/book | 14.0 | 3.24 | 1.91 – 7.00 | High |
| Price/sales | 24.9 | 4.10 | 2.84 – 11.0 | High |
| Gross margin | 90.9% | 74.7% | 61.5% – 79.2% | High |
| Operating margin | 38.4% | 22.2% | 15.1% – 32.7% | High |
| Net margin | 36.8% | 16.2% | 12.2% – 33.1% | High |
| ROE | 23.3% | 15.2% | 11.4% – 20.3% | High |
| Debt/equity | 0.03 | 0.21 | 0.03 – 0.41 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $526.33B
- Enterprise value
- $430.22B
- EV/revenue
- 17.5
Profitability and growth
- ROA
- 12.9%
- ROIC
- 14.8%
- Revenue growth (year over year)
- 90.3%
- Earnings growth (year over year)
- 203.5%
Financial health
- Total cash
- $26.76B
- Total debt
- $1.11B
- Current ratio
- 5.28
- Quick ratio
- 4.76
- Altman Z-Score
- 25.5
- Piotroski F-Score
- 7.00
Dividends
- Annual dividend per share
- $1.49
- Dividend yield
- 0.1%
- Payout ratio
- 6.8%
- Ex-dividend date
- July 9, 2026
Analysts and estimates
- Average price target
- $1,437.27
- Median price target
- $1,517.50
- High price target
- $2,143.00
- Low price target
- $500.33
- Analysts with a price target
- 8
- Consensus
- Buy
- EPS estimate, current year
- $25.86
Shares and trading
- Beta
- 0.65
- Average volume
- 3.4M
- Shares outstanding
- 414.43M
- Float
- 330.87M
- Institutional ownership
- 23.2%
- Insider ownership
- 8.1%
